In this work, we hypothesized that a prolonged delivery of the CIP peptide by fat-derived MSC may lead to improved post-stroke recovery by blocking neuronal and endothelial cell apoptosis through CDK5-p35 and subsequent p53 activation [17]. This evidence concerns the gene CDK5 and stroke disorder.